No results for ‘’
Vikram Thermo (India) Ltd
₹172
(0.58%)
Tue, 02 Jun 2026, 03:00 am
Health Technology
Pharmaceuticals: Major
24.5KVikram Thermo (India) Price to Cash Flow Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 10.52 | 7.74 | 6.44 | 5.42 | 5.31 | 3.79 | 3.20 | 4.49 | 5.15 | 13.16 | 8.29 | 14.06 | 24.88 | 9.45 | 5.99 | 8.52 | 14.11 | 11.33 | 18.82 | 67.72 |
| Price to book ratio | 1.75 | 1.62 | 1.64 | 0.89 | 1.04 | 0.94 | 1.08 | 1.16 | 1.11 | 1.42 | 1.09 | 1.77 | 1.51 | 0.98 | 0.82 | 1.57 | 1.67 | 2.14 | 4.21 | 4.52 |
| Price to sales ratio | 0.97 | 0.86 | 0.79 | 0.55 | 0.55 | 0.39 | 0.51 | 0.69 | 0.70 | 1.11 | 0.92 | 1.47 | 1.20 | 0.74 | 0.79 | 1.41 | 1.34 | 1.73 | 4.75 | 4.37 |
| Price to cash flow ratio | 9.10 | 4.32 | 4.77 | 4.66 | 14.96 | 4.25 | 3.10 | 4.03 | 6.29 | 19.88 | 14.03 | 11.45 | 21.17 | 15.97 | 3.50 | 7.12 | 23.20 | 15.94 | 21.52 | 23.88 |
| Enterprise value | 129.67M | 136.28M | 153.22M | 94.14M | 125.02M | 132.56M | 172.2M | 232.78M | 279.07M | 420.42M | 348.73M | 718.51M | 700.16M | 530.44M | 461.95M | 1.03B | 1.25B | 1.95B | 4.66B | 5.54B |
| Enterprise value to EBITDA ratio | 4.63 | 4.43 | 3.81 | 2.86 | 3.27 | 2.43 | 1.77 | 2.43 | 3.07 | 7.80 | 4.54 | 8.33 | 13.79 | 6.68 | 4.05 | 5.81 | 8.80 | 7.39 | 12.48 | 12.06 |
| Debt to equity ratio | 0.25 | 0.35 | 0.27 | 0.18 | 0.23 | 0.16 | 0.07 | 0.09 | 0.07 | 0.13 | 0.02 | 0.16 | 0.31 | 0.33 | 0.11 | 0.16 | 0.20 | 0.21 | 0.06 | 0.05 |
| Return on equity % | 0 | 21.63 | 27.37 | 17.22 | 20.99 | 26.94 | 39.42 | 29.01 | 23.74 | 11.26 | 13.87 | 13.54 | 6.27 | 10.86 | 14.85 | 20.07 | 12.49 | 20.73 | 25.65 | 28.73 |
Vikram Thermo (India) Ltd Price to Cash Flow Ratio
The Vikram Thermo (India) Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Vikram Thermo (India) Ltd's valuation, profitability, and overall financial performance. Tracking the Vikram Thermo (India) Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Vikram Thermo (India) Ltd (NSE: , BSE: 530477) is currently trading at ₹172, with a market capitalization of ₹5.32B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Vikram Thermo (India) Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Vikram Thermo (India) Ltd Price to Cash Flow Ratio Current Value
The current Vikram Thermo (India) Ltd Price to Cash Flow Ratio stands at 23.88.
The latest Vikram Thermo (India) Ltd Price to Cash Flow Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Vikram Thermo (India) Ltd Price to Cash Flow Ratio Historical Trend
The Vikram Thermo (India) Ltd Price to Cash Flow Ratio has shown the following historical trend:
- 2024: 23.88
- 2023: 21.52
- 2022: 15.94
- 2021: 23.20
- 2020: 7.12
The recent rise in Vikram Thermo (India) Ltd Price to Cash Flow Ratio suggests strengthening valuation trends and improving market sentiment.
What Vikram Thermo (India) Ltd Price to Cash Flow Ratio Indicates for Investors
The Vikram Thermo (India) Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Vikram Thermo (India) Ltd Price to Cash Flow Ratio Analysis Summary
The Vikram Thermo (India) Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Vikram Thermo (India) Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Vikram Thermo (India) Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.